Instituto Do Cancer Do Estado De São Paulo
Clinical trials sponsored by Instituto Do Cancer Do Estado De São Paulo, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo therapy targets Hard-to-Treat prostate cancer Results expected Sep 2026 (estimated)
- New robot arm takes on cancer surgery – first safety check begins Results expected Sep 2026 (estimated)
- New biopsy method may spare breast cancer patients from unnecessary surgery Results expected Nov 2026 (estimated)
- New dosing strategy aims to make liver cancer drug easier to tolerate Results expected Nov 2026 (estimated)
- New blood test could replace scans for HPV cancer patients Results expected Dec 2026 (estimated)
-
New dosing strategy aims to make liver cancer drug easier to tolerate
Disease control OngoingThis phase 2 trial tests whether slowly increasing the dose of the cancer drug regorafenib helps patients with advanced liver cancer tolerate it better. About 28 adults who have already tried one prior treatment will start at a low dose and increase weekly. The main goal is to se…
Phase 2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could one year of immunotherapy be enough for advanced melanoma?
Disease control OngoingThis phase 2 trial is testing whether one year of pembrolizumab (an immunotherapy drug) works as well as the standard two-year course for people with advanced melanoma that cannot be surgically removed. The study involves 29 participants in Brazil's public health system and measu…
Phase 2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a pill stop Post-Surgery nausea? trial tests oral amisulpride
Prevention OngoingResearchers are testing whether adding a 50 mg oral dose of amisulpride to standard anti-nausea drugs can prevent nausea and vomiting after gynecological surgery. The trial enrolls 276 women at high risk for postoperative nausea and vomiting who are having laparoscopic hysterecto…
Phase 2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC